Khan M, Zilani M, Hasan M, Hasan N
Heliyon. 2025; 11(4):e42594.
PMID: 40051864
PMC: 11883367.
DOI: 10.1016/j.heliyon.2025.e42594.
Chen J, Lin A, Jiang A, Qi C, Liu Z, Cheng Q
NPJ Digit Med. 2025; 8(1):44.
PMID: 39828791
PMC: 11743742.
DOI: 10.1038/s41746-025-01435-2.
Xue G, Tang L, Pan X, Li S, Zhao J
Front Oncol. 2024; 14:1520274.
PMID: 39737406
PMC: 11682985.
DOI: 10.3389/fonc.2024.1520274.
Werner S, Hegg L, Hopf N, Borgatta M, Suter-Dick L
Pharmacol Res Perspect. 2024; 12(6):e70037.
PMID: 39655648
PMC: 11629119.
DOI: 10.1002/prp2.70037.
Mohammed A, Kurucaovali F, Okvur D
J Pharmacokinet Pharmacodyn. 2024; 52(1):1.
PMID: 39630347
DOI: 10.1007/s10928-024-09955-2.
Riddelline from Tamarix articulate as a potential anti-bacterial lead compound for novel antibiotics discovery: A comprehensive computational and toxicological studies.
Alnuqaydan A
PLoS One. 2024; 19(11):e0310319.
PMID: 39541292
PMC: 11563397.
DOI: 10.1371/journal.pone.0310319.
Pharmacological Activities of and Its Derivative-"Chrysoeriol" in Skin Diseases.
Law S, Wu X, Jiang Z, Tong C, Chow W, Au D
Molecules. 2024; 29(9).
PMID: 38731465
PMC: 11085288.
DOI: 10.3390/molecules29091972.
Re-discover the value of protein binding assessments in hepatic and renal impairment studies and its contributions in drug labels and dose decisions.
Courville J, Roupe K, Arold G
Clin Transl Sci. 2024; 17(5):e13810.
PMID: 38716900
PMC: 11077687.
DOI: 10.1111/cts.13810.
Advancing probabilistic risk assessment by integrating human biomonitoring, new approach methods, and Bayesian modeling: A case study with the mycotoxin deoxynivalenol.
Lu E, Grimm F, Rusyn I, De Saeger S, De Boevre M, Chiu W
Environ Int. 2023; 182:108326.
PMID: 38000237
PMC: 10898272.
DOI: 10.1016/j.envint.2023.108326.
Diverse associations observed between pregnancy complications and RBC or plasma folates determined by an in-house developed LC-MS/MS method.
Xu Z, Li Y, Liu Y, Liu S, Zhang L, Wang J
Ann Med. 2023; 55(2):2265381.
PMID: 37824254
PMC: 10572033.
DOI: 10.1080/07853890.2023.2265381.
Design, and pharmacological evaluation of a peptide inhibitor of BACE-1.
Boldin R, Zychar B, Goncalves L, Sciani J
Front Pharmacol. 2023; 14:1184006.
PMID: 37397495
PMC: 10313070.
DOI: 10.3389/fphar.2023.1184006.
In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.
Tess D, Chang G, Keefer C, Carlo A, Jones R, Di L
AAPS J. 2023; 25(3):40.
PMID: 37052732
DOI: 10.1208/s12248-023-00800-x.
Delivering on the promise of protein degraders.
OBrien Laramy M, Luthra S, Brown M, Bartlett D
Nat Rev Drug Discov. 2023; 22(5):410-427.
PMID: 36810917
DOI: 10.1038/s41573-023-00652-2.
Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review.
Yalcin N, Surmelioglu N, Allegaert K
BMJ Paediatr Open. 2022; 6(1).
PMID: 36437518
PMC: 9639121.
DOI: 10.1136/bmjpo-2022-001512.
The plasma free fraction of 25-hydroxyvitamin D is not strongly associated with 25-hydroxyvitamin D clearance in kidney disease patients and controls.
Best C, Thummel K, Hsu S, Lin Y, Zelnick L, Kestenbaum B
J Steroid Biochem Mol Biol. 2022; 226:106206.
PMID: 36404469
PMC: 11536320.
DOI: 10.1016/j.jsbmb.2022.106206.
On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach.
Lim S, Lee S, Piao Y, Choi M, Bang D, Gu J
Comput Struct Biotechnol J. 2022; 20:4288-4304.
PMID: 36051875
PMC: 9399946.
DOI: 10.1016/j.csbj.2022.07.049.
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline.
Tanneau L, Karlsson M, Diacon A, Shenje J, De Los Rios J, Wiesner L
Clin Pharmacokinet. 2022; 61(8):1177-1185.
PMID: 35668346
PMC: 9349160.
DOI: 10.1007/s40262-022-01133-2.
Enhancing Atorvastatin In Vivo Oral Bioavailability in the Presence of Inflammatory Bowel Disease and Irritable Bowel Syndrome Using Supercritical Fluid Technology Guided by wbPBPK Modeling in Rat and Human.
Alsmadi M, Al-Daoud N, Obaidat R, Abu-Farsakh N
AAPS PharmSciTech. 2022; 23(5):148.
PMID: 35585214
DOI: 10.1208/s12249-022-02302-z.
Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug Discovery.
Naga D, Parrott N, Ecker G, Olivares-Morales A
Mol Pharm. 2022; 19(7):2203-2216.
PMID: 35476457
PMC: 9257750.
DOI: 10.1021/acs.molpharmaceut.2c00040.
Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia.
Versloot O, Iserman E, Chelle P, Germini F, Edginton A, Schutgens R
Hemasphere. 2022; 6(4):e694.
PMID: 35356797
PMC: 8939912.
DOI: 10.1097/HS9.0000000000000694.